Our study showed that the antioxidant systems of the cell are an important component of leukemia resistance to MTX, and targeting these pathways, especially the thioredoxin antioxidant system, may contribute to re-sensitize ALL to MTX. The gene discussed is TXN; the disease is leukemia.